The safety of treatment options for elderly people with acute myeloid leukemia.

about

AML therapy in the elderly: a time for a change.

P2860

Q40813160-E594EE32-6914-433A-A53B-52E953E1FF84

P2860

The safety of treatment options for elderly people with acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q38760822

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The safety of treatment options for elderly people with acute myeloid leukemia.

@en

type

Item

label

The safety of treatment options for elderly people with acute myeloid leukemia.

@en

prefLabel

The safety of treatment options for elderly people with acute myeloid leukemia.

@en

P1476

The safety of treatment options for elderly people with acute myeloid leukemia.

@en

P2093

Caroline Le Jeune

http://www.w3.org/2001/XMLSchema#string

Xavier Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

A phase 2 study of vorinostat in acute myeloid leukemia

The hallmarks of aging

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia.

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia.

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.

P304

635-645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2016.1161020

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26943698

http://www.w3.org/2001/XMLSchema#string

The safety of treatment options for elderly people with acute myeloid leukemia.

about

P2860

P2860

The safety of treatment options for elderly people with acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698